{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:52:30Z","timestamp":1790711550607,"version":"4.1.0"},"reference-count":19,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"\n Background & objectives:<\/jats:title>\n \n The prevalence of severe infections due to carbapenem-resistant\n Klebsiella pneumoniae<\/jats:italic>\n (CRKP) strains has increased worldwide. With rising resistance to polymyxins, the treatment has become challenging. Given the paucity of novel agents and limited data on combination therapy for CRKP, the present study was performed to test antibiotic combinations, for synergy against clinical isolates of CRKP.\n <\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n A total of 50 clinical isolates of CRKP were included. Modified carbapenem inactivation method was performed for the detection of carbapenemases.\n In vitro<\/jats:italic>\n synergy testing was done for the following combinations: meropenem+colistin, imipenem+tigecycline and polymyxin B+levofloxacin. It was performed with epsilometric test and microdilution checkerboard method. The time kill assay (TKA) was used to confirm the results. The fractional inhibitory concentration was also calculated.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n All CRKP isolates (100%) were ESBL producers and were completely resistant to amoxicillin-clavulanic acid, cefepime, cefotaxime, ceftazidime and piperacillin-tazobactam. Resistance to ciprofloxacin, amikacin and tetracycline was 96, 88 and 54 per cent, respectively. Overall, 78 (39\/50) and 88 per cent (44\/50) of the 50 CRKP isolates exhibited synergy by TKA for meropenem-colistin and imipenem-tigecycline, respectively. No synergy was detected for levofloxacin-polymyxin B combination. The best combination among the three was that of imipenem and tigecycline followed by meropenem-colistin.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Of the three combinations tested, imipenem and tigecycline followed by meropenem-colistin were found to be best. No synergy was detected for levofloxacin-polymyxin B combination.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_760_19","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T05:09:19Z","timestamp":1654492159000},"page":"520-526","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["In vitro evaluation of antibiotic synergy for carbapenem-resistant Klebsiella pneumoniae clinical isolates"],"prefix":"10.25259","volume":"154","author":[{"given":"Anku","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Palta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-19-20241212","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.3389\/fmicb.2018.03198","article-title":"High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and \u03b2-Lactamase Encoding Genes in a Brazilian Intensive Care Unit","volume":"9","author":"Ferreira","year":"2019","journal-title":"Front Microbiol"},{"key":"R2-19-20241212","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1473-3099(19)30431-1","article-title":"Bloodstream infections and carbapenem-resistant Enterobacteriaceae in South Korea","volume":"19","author":"Yoon","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R3-19-20241212","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R4-19-20241212","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase- producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R5-19-20241212","doi-asserted-by":"crossref","first-page":"ofz368","DOI":"10.1093\/ofid\/ofz368","article-title":"Emergent Polymyxin Resistance: End of an Era?","volume":"6","author":"Li","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R6-19-20241212","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fmicb.2019.00080","article-title":"Infections caused by carbapenem-resistant enterobacteriaceae: An update on therapeutic options","volume":"10","author":"Sheu","year":"2019","journal-title":"Front Microbiol"},{"key":"R11-19-20241212","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/ijmm.IJMM_17_189","article-title":"An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies","volume":"35","author":"Laishram","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"R13-19-20241212","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0255-0857.93054","article-title":"Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India","volume":"30","author":"Nagaraj","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"R14-19-20241212","doi-asserted-by":"crossref","first-page":"e22652","DOI":"10.1002\/jcla.22652","article-title":"Comparative evaluation of in- house Carba NP test with other phenotypic tests for rapid detection of carbapenem- resistant Enterobacteriaceae","volume":"33","author":"Bir","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"R15-19-20241212","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/AAC.00497-10","article-title":"Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug resistant Acinetobacter baumannii","volume":"54","author":"Sopirala","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R16-19-20241212","first-page":"1059","article-title":"Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections","volume":"3","author":"Townsend","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"R17-19-20241212","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/mdr.2016.0043","article-title":"Minocycline and tigecycline: What is their role in the treatment of carbapenem-resistant gram negative organisms?","volume":"23","author":"Shankar","year":"2016","journal-title":"Microb Drug Resist"},{"key":"R18-19-20241212","first-page":"39","article-title":"Time-Kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli","volume":"41","author":"Yim","year":"2011","journal-title":"Ann Clin Lab Sci"},{"key":"R19-19-20241212","first-page":"296","article-title":"In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended spectrum \u03b2-lactamase producing Klebsiella pneumoniae and Escherichia coli","volume":"23","author":"Cha","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R20-19-20241212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1179\/1973947814Y.0000000197","article-title":"Characterization of carbapenem resistance mechanisms in Klebsiella pneumoniae and in vitro synergy of the colistin-meropenem combination","volume":"27","author":"Krishnappa","year":"2015","journal-title":"J Chemother"},{"key":"R21-19-20241212","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1099\/jmm.0.000508","article-title":"The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India","volume":"66","author":"Manohar","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"R22-19-20241212","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0255-0857.83910","article-title":"Identification of plasmid-mediated quinolone resistance genes qnrA1, qnrB1 and aac (6\u2019)-1b-cr in a multiple drug-resistant isolate of Klebsiella pneumoniae from Chennai","volume":"29","author":"Magesh","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"R23-19-20241212","doi-asserted-by":"crossref","first-page":"105852","DOI":"10.1016\/j.ijantimicag.2019.11.009","article-title":"Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill\/in vivo Galleria mellonella survival model analysis","volume":"55","author":"Borjan","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R24-19-20241212","doi-asserted-by":"crossref","first-page":"622","DOI":"10.21037\/apm.2019.09.11","article-title":"Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro","volume":"8","author":"Zhang","year":"2019","journal-title":"Ann Palliat Med"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_760_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:04:23Z","timestamp":1751483063000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/in-vitro-evaluation-of-antibiotic-synergy-for-carbapenem-resistant-klebsiella-pneumoniae-clinical-isolates\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_760_19","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}